TherapeuticsMD (TXMD) Net Margin (2011 - 2026)
TherapeuticsMD's Net Margin was 17.84% in Q2 2026, down 40.04 percentage points from 57.88% a year earlier but up 4.72 percentage points from the prior quarter.
TherapeuticsMD (TXMD) Net Margin (2011 - 2026) Analysis & Trends
On a trailing twelve-month basis, TherapeuticsMD's Net Margin was -6.64% through Jun 30, 2026, up 11.30 percentage points year-over-year; for FY2025, it came in at -18.83%, up 105.02 percentage points from FY2024.
- Net Margin shows a five-year change of +264.07 percentage points (FY2020 to FY2025).
- In earlier years, Net Margin was -123.85% in FY2024 (+665.55 pp), -789.40% in FY2023 (-949.48 pp), 160.08% in FY2022 (+6861.01 pp) and -6700.93% in FY2021 (-6418.03 pp).
- Quarterly Net Margin has moved between -8182.20% (Q3 2022) and 32264.66% (Q2 2022) over five years.
- Compared with a year earlier, Net Margin was higher in six of the last eight quarters, with an average year-over-year change of +903.85 percentage points.
- The best year-over-year quarter for Net Margin over five years was Q2 2022 (a gain of 32450.09 percentage points); the worst was Q2 2023 (a drop of 32817.06 percentage points).
- Per Business Quant data, TXMD's Net Margin in the three quarters before Q2 2026 was 13.12% (Q1 2026), -69.32% (Q4 2025) and 19.39% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 30.88% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 21.86% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 21.27% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | -8.04% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 22.65% |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 16.30% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 23.62% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -134.51% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | -1.65% |
| 10 | TherapeuticsMD | 21.67 Mn | 21.67 Mn | - | 17.84% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.84% |
| Mar 31, 2026 | 13.12% |
| Dec 31, 2025 | -69.32% |
| Sep 30, 2025 | 19.39% |
| Jun 30, 2025 | 57.88% |
| Mar 31, 2025 | -166.16% |
| Dec 31, 2024 | 37.78% |
| Sep 30, 2024 | -111.33% |
| Jun 30, 2024 | -465.81% |
| Mar 31, 2024 | -234.50% |
| Dec 31, 2023 | -175.90% |
| Sep 30, 2023 | -6,373.58% |
| Jun 30, 2023 | -552.40% |
| Mar 31, 2023 | -866.11% |
| Dec 31, 2022 | 113.32% |
| Sep 30, 2022 | -8,182.20% |
| Jun 30, 2022 | 32,264.66% |
| Mar 31, 2022 | -7,053.38% |
| Dec 31, 2021 | -230.00% |
| Sep 30, 2021 | -186.65% |
TherapeuticsMD Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=TXMD&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "TXMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=TXMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();